# Ovarian Cancer Ovarian cancer gives shikonin a different kind of relevance. Here, the main story is less about direct tumour-cell killing and more about tumour-microenvironment signalling. ### Why ovarian cancer is a logical target Ovarian tumours often create a strongly immunosuppressive microenvironment. One part of that depends on tumour-derived exosomes that carry signals into nearby immune cells. Shikonin appears able to disrupt that communication channel. ### Key evidence In ovarian-cancer models, shikonin: * reduced exosome formation and secretion * blocked exosomal GAL3-mediated β-catenin activation * reduced M2-polarised macrophage presence in tumour-microenvironment models This is an unusual angle. It targets a tumour-support loop rather than only the tumour cell itself. ### Why this matters M2 macrophages help protect tumours from immune attack. They also support invasion, metastasis, and treatment resistance. Reducing exosome-driven M2 polarisation gives shikonin a credible microenvironment mechanism in ovarian cancer. ### Limits * evidence is still preclinical * immune-competent in vivo confirmation is limited * no interaction data with PARP inhibitors or platinum-based standard care * no subtype-specific evidence across serous, clear-cell, or endometrioid disease ### Bottom line Ovarian cancer is an early but mechanistically distinctive shikonin setting. The exosome and macrophage story is more specific than generic antiproliferative claims. It still needs much more validation before it can support clinical inference. ### References Frontiers in Pharmacology (2025). Review projecting shikonin as a therapeutic candidate in female reproductive cancers — exosome/GAL3/β-catenin and macrophage polarisation.\ {% hint style="warning" %} This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use. {% endhint %} {% hint style="info" %} © 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text. {% endhint %} --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/ovarian-cancer.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.